Danazol is a Oral Capsule in the Human Prescription Drug category. It is labeled and distributed by Teva Pharmaceuticals Usa, Inc.. The primary component is Danazol.
| Product ID | 0555-0635_22654f9f-0307-48aa-a28e-43ff43f86c94 |
| NDC | 0555-0635 |
| Product Type | Human Prescription Drug |
| Proprietary Name | Danazol |
| Generic Name | Danazol |
| Dosage Form | Capsule |
| Route of Administration | ORAL |
| Marketing Start Date | 1996-08-09 |
| Marketing Category | ANDA / ANDA |
| Application Number | ANDA074582 |
| Labeler Name | Teva Pharmaceuticals USA, Inc. |
| Substance Name | DANAZOL |
| Active Ingredient Strength | 200 mg/1 |
| Pharm Classes | Androgen Receptor Agonists [MoA],Androstanes [CS],Androgen [EPC] |
| NDC Exclude Flag | N |
| Listing Certified Through | 2022-12-31 |
| Marketing Start Date | 1996-08-09 |
| NDC Exclude Flag | N |
| Sample Package? | N |
| Marketing Category | ANDA |
| Application Number | ANDA074582 |
| Product Type | HUMAN PRESCRIPTION DRUG |
| Marketing Start Date | 1996-08-09 |
| Marketing End Date | 2012-02-14 |
| Marketing Category | ANDA |
| Application Number | ANDA074582 |
| Product Type | HUMAN PRESCRIPTION DRUG |
| Billing Unit | EA |
| Marketing Start Date | 1996-08-09 |
| Marketing Category | ANDA |
| Application Number | ANDA074582 |
| Product Type | HUMAN PRESCRIPTION DRUG |
| Billing Unit | EA |
| Marketing Start Date | 1996-08-09 |
| Ingredient | Strength |
|---|---|
| DANAZOL | 200 mg/1 |
| SPL SET ID: | e19acee5-ff33-45a5-bbbf-801756bc59b4 |
| Manufacturer | |
| UNII | |
| RxNorm Concept Unique ID - RxCUI |
| NDC | Brand Name | Generic Name |
|---|---|---|
| 0527-1368 | Danazol | Danazol |
| 0527-1369 | Danazol | Danazol |
| 0527-1392 | Danazol | Danazol |
| 0555-0633 | Danazol | Danazol |
| 0555-0634 | Danazol | Danazol |
| 0555-0635 | Danazol | Danazol |
| 42291-243 | Danazol | Danazol |
| 68151-2298 | Danazol | Danazol |
| 71205-861 | Danazol | Danazol |
| 71205-862 | Danazol | Danazol |